keratin.com, hair loss, baldness, alopecia, disease, and treatment information

alopecia areata and autoimmune disease pathogenesis

Hair Biology
Diagnosis / Decisions
Androgenetic Alopecia Biology
Androgenetic Alopecia Clinical Patterns
Androgenetic Alopecia Treatments
Hair Restoration
Alopecia Areata
Effluviums
Scarring Alopecias
Inflammatory Alopecias
Other Alopecias
Hair Shaft Defects
Infectious Hair Disease
Hirsutism / Hypertrichosis
Hair Color
Hair Cosmetics
Bits and Pieces
Immunology
Discussion Forums
Personal / Site Information


What is autoimmunity ?

AA is widely believed to be an autoimmune disease. A breakdown in the immune system results in autoimmunity. Essentially every individual produces various cell types that fight disease and infection. There are all sorts of immune cells such as lymphocytes, monocytes, macrophages and other cells, all of which have different roles to play in fighting off infection. To fight invading organisms the immune cells must be able to recognize bacteria (or whatever) as foreign and not part of the individual's own body. They do this by recognizing structures called antigens (antigens are usually proteins) on the surface of the invader. Every individual organism, including our ourselves, has a different set of antigens and the immune system as a whole can recognize all antigens with different immune cell clones/types recognizing different antigens.

Potentially the immune system can recognise any antigen on any bacteria, cell, or whatever, whether it is foreign or part of our own body. Those particular immune cells in our bodies that react with our own antigens must be prevented from coming into contact with the antigens or have their activity prohibited to stop them attacking and destroying our own organs. For the most part, prohibition of self reactive cells or prevention of contact with self antigens is done successfully, but inevitably within the complexities of the immune system things can go wrong. The development of an autoimmune disease can occur when potentially autoreactive cells escape our bodies' mechanisms of rendering them ineffective. The lymphocytes go to work with potentially catastrophic results on the organs where the antigens they are specific for are expressed.

The cause of the initiation of alopecia areata is not known but there is apparently a destructive response, mainly from lymphocytes and macrophages, to certain antigens in the hair follicle. There are several general hypotheses to explain the initiation of autoimmune diseases and just how our autoreactive cells become dangerous and destroy our own tissues. The main ones are described in more detail in the Immunology section of this web site.

ad003i1.shtml ad003i2.shtml ad003i3.shtml
The identity parade. Electron Microscope photographs of an antibody producing B cell, a macrophage and a lymphocyte. Normally good things to have but one or more of these cell types can be the perpetrators of autoimmune disease. Click pictures for larger views.


When autoimmune disease occurs in other organs the tissue is entirely destroyed. Why does this not happen in alopecia areata ?

When skin biopsies are examined alopecia areata affected hair follicles can often be seen to be still quite active. They are in a state called dystrophic anagen where follicles are producing root sheath material and often hair fibers - but they are too small and aberrant to protrude above the skin epidermis. White blood cells can be seen clustered in and around the hair follicle bulb and are presumably causing the disruption. However, there is no permanent destruction, under the right conditions the hair follicles can regrow normal hair. So this is an intriguing twist to classic autoimmune disease theory. In most autoimmune diseases the relevant organ(s) are attacked and eventually destroyed by the immune system. In alopecia areata the hair follicles are just disrupted and prohibited from producing hair.

Although most clinicians are convinced that autoimmunity is the root cause of alopecia areata, the classical interpretation of autoimmunity in this case is open to question. The immune system may be involved in inhibiting hair production via cell mediated activity, but considering there is a lack of total tissue destruction in alopecia areata, immune cells could be exerting their effects by more subtle means. For example, it has been suggested that the immune system is directed against a controlling hair growth promoter mechanism rather than actual hair follicle tissue (Price 1991, Rook 1991). Some investigators have suggested cytokines (chemical signals made by cells) produced by immune cells and hair follicles themselves may adversely affect the hair follicle (Goldsmith 1991). Or perhaps the antigen exists, or is exposed, for only a short time at the initiation of alopecia areata and thereafter alopecia areata is perpetuated by an imbalance in the immune system.

The most popular current hypothesis is that the hair follicles may drop out of their hair producing state into a telogen resting phase. This would mean the hair follicles would not express as many antigens and so antigenic stimulation of the immune cells would be reduced/removed. The immune cells would then disperse until the hair follicle reverted back to its active anagen state when the immune cells would return (McDonagh 1994). By running through this repeated cycle of events, or by remaining in telogen, the hair follicle could avoid the worst of the tissue destruction. Of course more than one of the above mechanisms may be in operation.


Is autoimmunity the most important cause of hair loss in alopecia areata ?

Many journal reports introduce the subject with a phrase along the lines of "the etiology of alopecia areata is entirely unknown" (eg Price 1991, Perret 1984, Paus 1993). Indirect evidence points towards hair loss being a result of immune system activity - an autoimmune disease. The evidence primarily consists of observation of an immune cell infiltrate in and around dystrophic hair follicles and the knowledge that some people with alopecia areata can regrow hair when undergoing immunosuppressive therapy (eg Gupta 1990). Further evidence comes from the association of alopecia areata with other autoimmune diseases. However, a small minority of dermatologists reject the idea of alopecia areata being an autoimmune disease.

Indirect evidence provided in support of an autoimmune mechanism is not incontrovertible. There are many theoretically possible, pathogenic pathways that may elicit hair loss in alopecia areata and lead to expression of an immune cell infiltrate. They can be classed into three main groups: 1) Third factor activity - the development of hair loss and the immune cell infiltrate in and around hair follicles is not because of interaction between the two. Rather, a third factor such as infection induces both hair loss and the immune response. 2) Autoimmunity induces disease - abnormal presentation of self and/or cross reactive antigens to the immune system evokes an immune cell infiltrate as a "first line of defence" and primary trigger for the onset of alopecia areata. In other words, the immune system is acting abnormally against a normally functioning hair follicle. 3) Disease induces autoimmunity - hair follicle tissue damage or abnormal follicle activity may result in exposure of self antigens to the immune system. Or expression of non-self antigens on hair follicle cells, as would occur if they were virally infected, may precipitate an immune response to the non-self antigen which also adversely affects surrounding tissues. In other words, the immune system is acting normally against an abnormally functioning hair follicle.

We need evidence to support or refute these three possibilities. What precipitates the infiltrate of immune cells in and around hair follicles in the first place is unknown. In classic autoimmunity the initiation would be attributed to autoreactive antigens situated in the hair follicle which would be attacked by the immune system. But so far suspect antigens that should be present in the hair follicles of alopecia areata patients have not been identified and the mechanism by which hair loss is induced is not known.


Alopecia areata and autoimmune disease references

  • McElwee KJ, Tobin DJ, Bystryn JC, King LE Jr, Sundberg JP. Alopecia areata: an autoimmune disease? Exp Dermatol. 1999 Oct;8(5):371-9.
  • Colombe BW, Lou CD, Price VH. The genetic basis of alopecia areata: HLA associations with patchy alopecia areata versus alopecia totalis and alopecia universalis. J Investig Dermatol Symp Proc. 1999 Dec;4(3):216-9.
  • Cork MJ, Crane AM, Duff GW. Genetic control of cytokines. Cytokine gene polymorphisms in alopecia areata. Dermatol Clin. 1996 Oct;14(4):671-8.
  • Paus R, Slominski A, Czarnetzki BM. Is alopecia areata an autoimmune-response against melanogenesis-related proteins, exposed by abnormal MHC class I expression in the anagen hair bulb? Yale J Biol Med. 1993 Nov-Dec;66(6):541-54.
  • Westgate GE, Craggs RI, Gibson WT. Immune privilege in hair growth. J Invest Dermatol. 1991 Sep;97(3):417-20.
  • Khoury EL, Price VH, Greenspan JS. HLA-DR expression by hair follicle keratinocytes in alopecia areata: evidence that it is secondary to the lymphoid infiltration. J Invest Dermatol. 1988 Feb;90(2):193-200.
  • Brocker EB, Echternacht-Happle K, Hamm H, Happle R. Abnormal expression of class I and class II major histocompatibility antigens in alopecia areata: modulation by topical immunotherapy. J Invest Dermatol. 1987 May;88(5):564-8.
  • Messenger AG, Bleehen SS. Expression of HLA-DR by anagen hair follicles in alopecia areata. J Invest Dermatol. 1985 Dec;85(6):569-72.
  • McDonagh AJ, Messenger AG. Alopecia areata. Clin Dermatol. 2001 Mar-Apr;19(2):141-7.
  • Theofilopoulos AN, Kono DH. Mechanisms and genetics of autoimmunity. Ann N Y Acad Sci. 1998 May 13;841:225-35.
  • Paus R. Immunology of the hair follicle. In: Bos JD, ed. Skin immune system (SIS) Cutaneous immunology and clinical immunodermatology, 2nd edition. Boca Ranton: CRC press, 1997: 377-398.
  • McDonagh AJ, Messenger AG. The pathogenesis of alopecia areata. Dermatol Clin. 1996 Oct;14(4):661-70.
  • Theofilopoulos AN. The basis of autoimmunity: Part I. Mechanisms of aberrant self-recognition. Immunol Today. 1995 Feb;16(2):90-8.
  • Theofilopoulos AN. The basis of autoimmunity: Part II. Genetic predisposition. Immunol Today. 1995 Mar;16(3):150-9.
  • Matzinger P. Tolerance, danger and the extended family. Ann Rev Immunol 1994; 12: 991-1045.
  • McDonagh AJ, Messenger AG. The aetiology and pathogenesis of alopecia areata. J Dermatol Sci. 1994 Jul;7 Suppl:S125-35.
  • Rose NR, Bona C. Defining criteria for autoimmune diseases (Witebsky's postulates revisited) Immunol Today. 1993 Sep;14(9):426-30.
  • Price VH, Khoury EL. Alopecia areata. Prog Dermatol 1991; 25: 1-7.
  • Goldsmith LA. Summary of alopecia areata research workshop and future research directions. J Invest Dermatol 1991; 96: 98s?100s.
  • Perret C, Weisner-Menzel L, Happle R. Immunohistochemical analysis of T-cell subsets in the peribulbar and intrabulbar infiltrates of alopecia areata. Acta Derm Venerol 1984; 64: 26-30.
  • Ranki A, Kianto U, Kanerva L, Tolvanen E, Johansson E. Immunohistochemical and electron microscopic characterization of the cellular infiltrate in alopecia (areata, totalis, and universalis). J Invest Dermatol 1984; 83: 7-11.
  • Barker CF, Billingham RE: Immunologically privileged sites. Adv Immunol 1977; 25: 1-54.
  • Burnet FM. The clonal selection theory of acquired immunity. London: Cambridge University Press, 1959.

Top of the page

Copyright ©. All Rights Reserved
http://www.keratin.com
Top of the page